Literature DB >> 24394895

Sodium and potassium intakes and blood pressure in Chinese adults in Hong Kong: A comparison with southern China.

T Y Chan1, A Y Chan, J T Lau, J A Critchley.   

Abstract

The ranges of sodium and potassium intake and their relationship to blood pressure were studied in 126 healthy Chinese subjects (42 men, 84 women) aged between 20 and 65 years living in Hong Kong. An average of three blood pressure measurements and one to three 24-hour urinary sodium and potassium outputs were used to characterize an individual's blood pressure, and sodium and potassium intake, respectively. The average sodium and potassium intakes were 145 and 40 mmol/day in men and 135 and 41 mmol/day in women. When compared with subjects of similar age in southern China, Chinese in Hong Kong excreted 20% less sodium but 40% more potassium and had a lower systolic blood pressure (113 vs 118 mmHg in men, 106 vs 112 mmHg in women). It should be remembered that the Hong Kong subjects were heavier and were under more urban stress, both of which would be expected to be associated with higher blood pressure. The findings from this pilot study are compatible with a positive association between sodium intake and blood pressure and/or an inverse association between potassium intake and blood pressure.

Entities:  

Year:  1998        PMID: 24394895

Source DB:  PubMed          Journal:  Asia Pac J Clin Nutr        ISSN: 0964-7058            Impact factor:   1.662


  2 in total

1.  Twenty-Four-Hour Urinary Sodium and Potassium Excretion in China: A Systematic Review and Meta-Analysis.

Authors:  Monique Tan; Feng J He; Changqiong Wang; Graham A MacGregor
Journal:  J Am Heart Assoc       Date:  2019-07-11       Impact factor: 5.501

2.  Association between the Urinary Sodium to Potassium Ratio and Blood Pressure in Adults: A Systematic Review and Meta-Analysis.

Authors:  Rhoda N Ndanuko; Rukayat Ibrahim; Retno A Hapsari; Elizabeth P Neale; David Raubenheimer; Karen E Charlton
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 11.567

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.